Human leucocyte antigen supertypes and immune susceptibility to HIV-1, implications for vaccine design.
MacDonald KS, Matukas L, Embree JE, Fowke K, Kimani J, Nagelkerke NJ, Oyugi J, Kiama P, Kaul R, Luscher MA, Rowland-Jones S, Ndinya-Achola J, Ngugi E, Bwayo JJ, Plummer FA.
MacDonald KS, et al.
Immunol Lett. 2001 Nov 1;79(1-2):151-7. doi: 10.1016/s0165-2478(01)00277-2.
Immunol Lett. 2001.
PMID: 11595302